0001213900-25-009136.txt : 20250203 0001213900-25-009136.hdr.sgml : 20250203 20250203084905 ACCESSION NUMBER: 0001213900-25-009136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250111 FILED AS OF DATE: 20250203 DATE AS OF CHANGE: 20250203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULL ANDREW CENTRAL INDEX KEY: 0001818252 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 25580764 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 4 1 ownership.xml X0508 4 2025-01-11 0 0001728328 InMed Pharmaceuticals Inc. INM 0001818252 HULL ANDREW C/O INMED PHARMACEUTICALS INC. 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C3E8 BRITISH COLUMBIA, CANADA 1 0 0 0 0 Employee Stock Option (Expiration) 2860.21 2025-01-11 4 H 0 2 0.00 D 2020-01-12 2025-01-11 Common shares 2 975 D Converted from the Canadian dollar exercise price of C$4,125.00 using an exchange rate of C$1.4422 = $US1.00 /s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull 2025-02-03